Roach Jared C, Rapozo Molly K, Hara Junko, Glusman Gwênlyn, Lovejoy Jennifer, Shankle William R, Hood Leroy
Institute for Systems Biology, Seattle, WA, USA.
Providence St. Joseph Health, Renton, WA, USA.
J Alzheimers Dis. 2023;96(2):591-607. doi: 10.3233/JAD-230403.
Comprehensive treatment of Alzheimer's disease and related dementias (ADRD) requires not only pharmacologic treatment but also management of existing medical conditions and lifestyle modifications including diet, cognitive training, and exercise. Personalized, multimodal therapies are needed to best prevent and treat Alzheimer's disease (AD).
The Coaching for Cognition in Alzheimer's (COCOA) trial was a prospective randomized controlled trial to test the hypothesis that a remotely coached multimodal lifestyle intervention would improve early-stage AD.
Participants with early-stage AD were randomized into two arms. Arm 1 (N = 24) received standard of care. Arm 2 (N = 31) additionally received telephonic personalized coaching for multiple lifestyle interventions. The primary outcome was a test of the hypothesis that the Memory Performance Index (MPI) change over time would be better in the intervention arm than in the control arm. The Functional Assessment Staging Test was assessed for a secondary outcome. COCOA collected psychometric, clinical, lifestyle, genomic, proteomic, metabolomic, and microbiome data at multiple timepoints (dynamic dense data) across two years for each participant.
The intervention arm ameliorated 2.1 [1.0] MPI points (mean [SD], p = 0.016) compared to the control over the two-year intervention. No important adverse events or side effects were observed.
Multimodal lifestyle interventions are effective for ameliorating cognitive decline and have a larger effect size than pharmacological interventions. Dietary changes and exercise are likely to be beneficial components of multimodal interventions in many individuals. Remote coaching is an effective intervention for early stage ADRD. Remote interventions were effective during the COVID pandemic.
阿尔茨海默病及相关痴呆症(ADRD)的综合治疗不仅需要药物治疗,还需要对现有医疗状况进行管理以及进行生活方式调整,包括饮食、认知训练和运动。需要个性化的多模式疗法来最佳地预防和治疗阿尔茨海默病(AD)。
阿尔茨海默病认知指导(COCOA)试验是一项前瞻性随机对照试验,旨在检验远程指导的多模式生活方式干预可改善早期AD这一假设。
早期AD患者被随机分为两组。第1组(N = 24)接受标准治疗。第2组(N = 31)额外接受针对多种生活方式干预的电话个性化指导。主要结局是检验干预组随时间变化的记忆表现指数(MPI)优于对照组这一假设。对功能评估分期测试进行次要结局评估。COCOA在两年内的多个时间点(动态密集数据)为每位参与者收集了心理测量、临床、生活方式、基因组、蛋白质组、代谢组和微生物组数据。
在为期两年的干预中,与对照组相比,干预组的MPI改善了2.1[1.0]分(均值[标准差],p = 0.016)。未观察到重要不良事件或副作用。
多模式生活方式干预对改善认知衰退有效,且效应量大于药物干预。饮食改变和运动可能是许多个体多模式干预的有益组成部分。远程指导是早期ADRD的有效干预措施。在新冠疫情期间远程干预有效。